Jason Aryeh

Affiliations

  • Director at Ligand Pharmaceuticals Inc (LGND), 2025-06-10
  • Director at Anebulo Pharmaceuticals Inc. (ANEB), 2025-04-08
  • Director at Orchestra Biomed Holdings Inc. (OBIO), 2024-12-30
  • Director at Lifecore Biomedical Inc. (LFCR), 2024-08-21
  • Large Shareholder, Other at Merrimack Pharmaceuticals Inc (MACK), 2019-07-18
  • Director at Aralez Pharmaceuticals Inc. (ARLZ), 2017-05-24
  • Director at Novelion Therapeutics Inc. (NVLN), 2017-05-17
  • Director at Immunomedics Inc (IMMU), 2017-01-11
  • Director at Myrexis Inc. (MYRX), 2012-06-20
  • Director at Nabi Biopharmaceuticals (NABI), 2011-05-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LGND $87.01 750 $65,257.50 67,203 2019-09-03 Filing
LGND $90.01 746 $67,145.97 66,453 2019-08-05 Filing
LGND $93.00 754 $70,121.55 65,707 2019-07-31 Filing
LGND $100.22 3,000 $300,662.70 64,953 2019-07-30 Filing
LGND $106.01 250 $26,502.50 61,953 2019-07-29 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LGND $241.81 26,862 $6,495,559.32 51,392 2018-08-17 Filing
LGND $245.00 1,080 $264,600.00 78,254 2018-08-16 Filing
LGND $176.47 4,000 $705,898.80 79,334 2018-03-09 Filing
LGND $174.88 3,500 $612,095.05 83,334 2018-03-08 Filing
LGND $155.00 3,417 $529,635.00 86,834 2018-02-23 Filing